These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6527680)

  • 1. [Distribution of ethanolamine oleate after injection in esophageal varices].
    Sukigara M; Taguchi Y; Yamazaki T; Koga K; Miyamae T; Omoto R
    Nihon Geka Gakkai Zasshi; 1984 Dec; 85(12):1523-7. PubMed ID: 6527680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic dissemination of ethanolamine oleate after injection sclerotherapy for esophageal varices.
    Sukigara M; Omoto R; Miyamae T
    Arch Surg; 1985 Jul; 120(7):833-6. PubMed ID: 2990382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices.
    Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K
    Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemorrhagic duodenal varices treated successfully with endoscopic injection sclerotherapy using cyanoacrylate and ethanolamine-oleate: a case report.
    Suzuki R; Irisawa A; Hikichi T; Shibukawa G; Takagi T; Wakatsuki T; Imamura H; Takahashi Y; Sato A; Sato M; Ikeda T; Tasaki K; Obara K; Ohira H
    Surg Laparosc Endosc Percutan Tech; 2009 Dec; 19(6):e233-6. PubMed ID: 20027076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized study comparing the effects of large and small volumes of the sclerosant 5% ethanolamine oleate injected into esophageal varices.
    Iso Y; Kitano S; Iwanaga T; Koyanagi N; Sugimachi K
    Endoscopy; 1988 Nov; 20(6):285-8. PubMed ID: 3229387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An experimental study on hepatotoxicity of sclerosant ethanolamine oleate flowed into portal vein.
    Kobashi S; Yamada R; Kaminou T; Ikura Y; Ueda M
    Osaka City Med J; 2001 Jun; 47(1):53-62. PubMed ID: 11556392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethanolamine oleate versus absolute alcohol as a variceal sclerosant: a prospective, randomized, controlled trial.
    Sarin SK; Mishra SP; Sachdev GK; Thorat V; Dalal L; Broor SL
    Am J Gastroenterol; 1988 May; 83(5):526-30. PubMed ID: 3284336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The destructive effects of sclerosant ethanolamine oleate on mammalian vessel endothelium.
    Masaki M; Obara K; Suzuki S; Orikasa K; Mitsuhashi H; Iwasaki K; Sakamoto H; Morito T; Kasukawa R
    Gastroenterol Jpn; 1990 Apr; 25(2):230-5. PubMed ID: 2347476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of esophageal varices: low versus high dose of 5% ethanolamine oleate.
    Neeman A; Leiser A; Kadish U
    Am J Gastroenterol; 1991 Sep; 86(9):1182-4. PubMed ID: 1882797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethanolamine oleate is superior to polidocanol (aethoxysklerol) for endoscopic injection sclerotherapy of esophageal varices: a prospective randomized trial.
    Kitano S; Iso Y; Koyanagi N; Higashi H; Sugimachi K
    Hepatogastroenterology; 1987 Feb; 34(1):19-23. PubMed ID: 3552917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human thrombin plus 5 per cent ethanolamine oleate injected to sclerose oesophageal varices: a prospective randomized trial.
    Kitano S; Hashizume M; Yamaga H; Wada H; Iso Y; Iwanaga T; Sugimachi K
    Br J Surg; 1989 Jul; 76(7):715-8. PubMed ID: 2765808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete eradication of duodenal varices after endoscopic injection sclerotherapy with ethanolamine oleate: a case report.
    Seo YS; Kwon YD; Park S; Keum B; Park BJ; Kim YS; Jeen YT; Chun HJ; Kim CD; Ryu HS; Um SH
    Gastrointest Endosc; 2008 Apr; 67(4):759-62. PubMed ID: 18206152
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathological studies on esophageal varices treated with injection sclerotherapy.
    Takase Y; Kikuchi M; Ozaki A; Shibuya S; Iwasaki Y
    Jpn J Surg; 1985 Jan; 15(1):30-5. PubMed ID: 3990047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison with percutaneous transhepatic embolization and endoscopic injection sclerotherapy in esophageal varices].
    Kimura K; Morita M; Matsutani S; Saisho H; Ohto M; Okuda K
    Nihon Rinsho; 1984 Oct; 42(10):2332-6. PubMed ID: 6520961
    [No Abstract]   [Full Text] [Related]  

  • 15. A sclerosant with astringent properties developed in China for oesophageal varices: comparison with ethanolamine oleate and polidocanol.
    Nishida R; Inoue R; Takimoto Y; Kita T
    J Gastroenterol Hepatol; 1999 May; 14(5):481-8. PubMed ID: 10355514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental studies on respiratory insufficiency after endoscopic injection sclerotherapy using ethanolamine-oleate].
    Umekita N
    Nihon Geka Gakkai Zasshi; 1986 Feb; 87(2):172-9. PubMed ID: 3713671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squamous cell carcinoma after endoscopic injection sclerotherapy for esophageal varices.
    Kokudo N; Sanjo K; Umekita N; Harihara Y; Tada Y; Idezuki Y
    Am J Gastroenterol; 1990 Jul; 85(7):861-4. PubMed ID: 2196786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet aggregability after endoscopic intravariceal injection of 5 per cent ethanolamine oleate into oesophageal varices.
    Yamaga H; Hashizume M; Kitano S; Higashi H; Sugimachi K
    Br J Surg; 1989 Sep; 76(9):939-42. PubMed ID: 2804591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endoscopic sclerotherapy of esophageal varices in pediatric patients].
    Salvatierra A; Granella L; Guevara ML; Barrios M; García MI; Salvatierra L
    G E N; 1992; 46(1):1-3. PubMed ID: 1305111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological and hemodynamic changes of the lung after injection of 5% ethanolamine oleate into dogs.
    Iso Y; Kitano S; Iwanaga T; Hashizume M; Sugimachi K
    Eur Surg Res; 1989; 21(3-4):175-83. PubMed ID: 2806345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.